These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Toxicological Characterization and Phospholipase D Activity of the Venom of the Spider Arán-Sekul T; Perčić-Sarmiento I; Valencia V; Olivero N; Rojas JM; Araya JE; Taucare-Ríos A; Catalán A Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33171968 [TBL] [Abstract][Full Text] [Related]
11. Forty Years of the Description of Brown Spider Venom Phospholipases-D. Gremski LH; da Justa HC; da Silva TP; Polli NLC; Antunes BC; Minozzo JC; Wille ACM; Senff-Ribeiro A; Arni RK; Veiga SS Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32155765 [TBL] [Abstract][Full Text] [Related]
12. The relationship between calcium and the metabolism of plasma membrane phospholipids in hemolysis induced by brown spider venom phospholipase-D toxin. Chaves-Moreira D; Souza FN; Fogaça RT; Mangili OC; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS J Cell Biochem; 2011 Sep; 112(9):2529-40. PubMed ID: 21590705 [TBL] [Abstract][Full Text] [Related]
13. Phospholipase-D activity and inflammatory response induced by brown spider dermonecrotic toxin: endothelial cell membrane phospholipids as targets for toxicity. Chaim OM; da Silveira RB; Trevisan-Silva D; Ferrer VP; Sade YB; Bóia-Ferreira M; Gremski LH; Gremski W; Senff-Ribeiro A; Takahashi HK; Toledo MS; Nader HB; Veiga SS Biochim Biophys Acta; 2011 Feb; 1811(2):84-96. PubMed ID: 21094694 [TBL] [Abstract][Full Text] [Related]
14. Antigenic and Substrate Preference Differences between Scorpion and Spider Dermonecrotic Toxins, a Comparative Investigation. Ben Yekhlef R; Felicori L; Santos LH; F B Oliveira C; Fadhloun R; Torabi E; Shahbazzadeh D; Pooshang Bagheri K; Salgado Ferreira R; Borchani L Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019554 [TBL] [Abstract][Full Text] [Related]
15. A protective vaccine against the toxic activities following Brown spider accidents based on recombinant mutated phospholipases D as antigens. Polli NLC; Justa HCD; Antunes BC; Silva TPD; Dittrich RL; de Souza GS; Wille ACM; Matsubara FH; Minozzo JC; Mariutti RB; Arni RK; Senff-Ribeiro A; Veiga SS; Gremski LH Int J Biol Macromol; 2021 Dec; 192():757-770. PubMed ID: 34634338 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory events induced by brown spider venom and its recombinant dermonecrotic toxin: a pharmacological investigation. Paludo KS; Biscaia SM; Chaim OM; Otuki MF; Naliwaiko K; Dombrowski PA; Franco CR; Veiga SS Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):323-33. PubMed ID: 19041422 [TBL] [Abstract][Full Text] [Related]
17. Novel insights into the application of recombinant mutated phospholipases D as antigens for developing new strategies against Loxoscelism. Polli NLC; Ferreira MEF; Schluga PHC; Antunes BC; Justa HCD; Theodoro JL; Zazula MF; Naliwaiko K; Minozzo JC; Senff-Ribeiro A; Wille ACM; Veiga SS; Gremski LH Acta Trop; 2024 Oct; 258():107354. PubMed ID: 39106916 [TBL] [Abstract][Full Text] [Related]
18. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia). Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081 [TBL] [Abstract][Full Text] [Related]
19. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484 [TBL] [Abstract][Full Text] [Related]
20. Brown Spider Venom Phospholipase-D Activity upon Different Lipid Substrates. Chaves-Moreira D; Gremski LH; de Moraes FR; Vuitika L; Wille ACM; Hernández González JE; Chaim OM; Senff-Ribeiro A; Arni RK; Veiga SS Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]